Editas Medicine Inc. (EDIT)
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.75 0.00%
EDIT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $422.35M
- EPS (TTM)
- -$0.68
- Dividend yield
- None
- 52-week range
- 1.66 – 4.54
- Day range
- 2.66 – 2.85
- Volume / Avg
- 2.26M / 2.48M
- Beta
- —
- Shares outstanding
- 153.58M
52-week range
EDIT stock today
Shares of Editas Medicine (EDIT) finished higher on Oct 7 at $2.75, a gain of 0.73% or $0.02 per share, versus the S&P 500's 0.22% decline. At this level, EDIT sits in the middle of its 52-week range of $1.66 to $4.54: 39.4% below the high and 65.7% above the low. Editas Medicine has posted a net loss over the last twelve months (EPS of -$0.68), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Editas Medicine
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2016
Editas Medicine peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EIKNEikon Therapeutics Inc. | 7.54 | +0.40% | $408.40M | vs EDIT |
| AGMBAgomAb Therapeutics NV ADR | 8.80 | -0.45% | $433.38M | vs EDIT |
| ENTXEntera Bio Ltd. | 2.51 | -0.79% | $436.32M | vs EDIT |
| ZURAZura Bio Limited Class A | 4.17 | +5.30% | $399.61M | vs EDIT |
| TECXTectonic Therapeutic Inc. | 22.71 | +1.34% | $443.97M | vs EDIT |
| KYTXKyverna Therapeutics Inc. | 6.17 | +0.16% | $381.57M | vs EDIT |
| FENCFennec Pharmaceuticals Inc. | 10.36 | +0.10% | $363.30M | vs EDIT |
| AUTLAutolus Therapeutics plc ADR | 1.81 | +1.12% | $481.75M | vs EDIT |
Indexes, lists and sector
Largest Health Care stocks
Editas Medicine stock FAQ
What is Editas Medicine's stock price today?
EDIT last traded at $2.75 as of Oct 7, 4:00 PM EDT, up 0.73% on the day. Prices are delayed at least 15 minutes.
What is the EDIT 52-week high?
The 52-week high for EDIT is $4.54 and the 52-week low is $1.66. The stock is currently 39.4% below its high.